17e_JJ
GROUP_NN
BALANCE_NN
SHEET_NN
At_PIN
31_CD
December_NN
Stock_NN
2002 2001 2002_CD
is_VPRT [BEMA]
the_DT
first_JJ
year_NN
that_DEMP
Acambis_NN
Notes_NN
000_CD
000_CD
has_VPRT [PEAS]
recognized_VBN [PRIV]
stock_NN
on_PIN
the_DT
balance_NN
Fixed_VBN
assets_NN
sheet_NN
._.
This_DEMO
largely_RB
reflects_VPRT [PRIV]
work-inIntangible_JJ
assets_NN
:_:
goodwill_NN
12_CD
13,641_CD
14,845_CD
progress_NN
and_CC
finished_VBD
goods_NN
under_IN
Tangible_JJ
assets_NN
13_CD
19,988_CD
12,255_CD
the_DT
second_JJ
CDC_NN
smallpox_NN
vaccine_NN
Investment_NOMZ
in_PIN
joint_JJ
ventures_NN
:_:
14_CD
contract_NN
._.
share_NN
of_PIN
gross_JJ
assets_NN
-_:
915_CD
share_NN
of_PIN
gross_JJ
liabilities_NOMZ
-_:
848_SYM
-_:
67_CD
Debtors_NN
:_:
amounts_NN
receivable_NN
within_PIN
Other_JJ
investments_NOMZ
14_CD
1,100_CD
1,640_CD
one_CD
year_NN
34,729_CD
28,807_CD
This_DEMP
includes_VPRT
amounts_NN
invoiced_VBD
but_CC
Current_JJ
assets_NN
not_XX0
received_VBD
at_PIN
the_DT
year-end_NN
of_PIN
Stock_NN
15_CD
48,343_CD
-_:
46.1_CD
m_NN
,_,
principally_RB
from_PIN
the_DT
CDC_NN
._.
Debtors_NN
:_:
amounts_NN
receivable_NN
within_PIN
one_CD
year_NN
16_CD
54,040_CD
7,542_CD
Debtors_NN
:_:
amounts_NN
receivable_NN
after_IN
one_CD
year_NN
17_CD
4,925_CD
6,235_CD
Cash_NN
at_PIN
bank_NN
and_CC
in_PIN
hand_NN
Short-term_JJ
investments_NOMZ
105_CD
120_CD
Cash_NN
at_PIN
the_DT
year-end_NN
was_VBD [BEMA]
11.7_CD
m._FW
Cash_NN
at_PIN
bank_NN
and_CC
in_PIN
hand_NN
11,672_CD
22,093_CD
We_FPP1
received_VBD
two_CD
significant_JJ
payments_NOMZ
119,085_CD
35,990_CD
two_CD
days_NN
after_IN
the_DT
year-end_NN
which_WDT [WHOBJ]
,_,
Creditors_NN
:_:
amounts_NN
falling_VBG [WZPRES]
due_JJ
within_PIN
one_CD
year_NN
18_CD
88,460_CD
16,603_CD
had_VBD [PEAS]
they_TPP3
been_VBN [PASS]
received_VBN
two_CD
days_NN
Net_JJ
current_JJ
assets_NN
30,625_CD
19,387_CD
earlier_TIME
,_,
would_PRMD
have_VB [PEAS]
increased_VBN
the_DT
cash_NN
Total_JJ
assets_NN
less_RB
current_JJ
liabilities_NOMZ
65,354_CD
48,194_CD
position_NOMZ
significantly_RB
._.
These_DEMO
large_JJ
post_NN
Creditors_NN
:_:
amounts_NN
falling_VBG [WZPRES]
due_JJ
after_IN
one_CD
year_NN
19_CD
18,897_CD
20,534_CD
year-end_NN
receipts_NN
are_VPRT [PASS]
reflected_VBN [PRIV]
Provisions_NN
for_PIN
liabilities_NOMZ
and_PHC
charges_NN
in_PIN
the_DT
large_JJ
debtors_NN
balance_NN
at_PIN
Investment_NOMZ
in_PIN
joint_JJ
ventures_NN
:_:
14_CD
d_SYM
31_CD
December_NN
2002_CD
of_PIN
59.0_CD
m._JJ
share_NN
of_PIN
assets_NN
941_CD
-_:
share_NN
of_PIN
liabilities_NOMZ
1,147_CD
-_:
We_FPP1
expect_VPRT [PRIV]
to_TO
have_VB
over_IN
100m_CD
in_PIN
cash_NN
206_CD
-_:
Net_JJ
assets_NN
46,251_CD
27,660_CD
by_PIN
the_DT
end_NN
of_PIN
2003_CD
._.
Capital_NN
and_PHC
reserves_NN
Creditors_NN
:_:
amounts_NN
falling_VBG [WZPRES]
due_JJ
Called-up_JJ
share_NN
capital_NN
21_CD
9,901_CD
9,308_CD
within_PIN
one_CD
year_NN
Share_NN
premium_NN
account_NN
22_CD
87,745_CD
80,598_CD
The_DT
increase_NN
in_PIN
trade_NN
creditors_NN
and_PHC
Profit_NN
and_PHC
loss_NN
account_NN
22_CD
51,395_CD
62,246_CD
deferred_VBN
revenue_NN
has_VPRT [PEAS]
arisen_VBN
Shareholders_NN
funds_NN
all_QUAN
equity_NOMZ
23_CD
46,251_CD
27,660_CD
principally_RB
from_PIN
the_DT
second_JJ
CDC_NN
smallpox_NN
vaccine_NN
contract_NN
._.
The_DT
accompanying_JJ
notes_NN
are_VPRT [BEMA]
an_DT
integral_JJ
part_NN
of_PIN
this_DEMO
Group_NN
balance_NN
sheet_NN
._.
THE_DT
INFORMATION_NOMZ
CONTAINED_VBD
IN_PIN
THIS_DEMO
COLUMN_NN
HAS_VPRT
NOT_XX0
BEEN_JJ
AUDITED_NN
._.
